Author:
Briggs Katharine T.,Taraban Marc B.,Wang Weizhen,Yu Y. Bruce
Funder
National Institute for Innovation in Manufacturing Biopharmaceuticals
Center for Excellence in Regulatory Science and Innovation, University of Maryland
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference26 articles.
1. U.S. Food and Drug Administration (FDA). MAUDE adverse event report: Novo Nordisk A/S Novopen insulin delivery device 2013.
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi__id=3621493
. Accessed 09 Feb 2018.
2. Ben Salem C, Fathallah N, Hmouda H, Bouraoui K. Drug-induced hypoglycaemia. Drug Saf. 2011;34:21–45.
https://doi.org/10.2165/11538290-000000000-00000
.
3. McCall AL. Insulin therapy and hypoglycemia. Endocrinol Metab Clin N Am. 2012;41:57–87.
https://doi.org/10.1016/j.ecl.2012.03.001
.
4. European Medicines Agency (EMA). Batches of the insulin medicine NovoMix 30 FlexPen and Penfill to be recalled, (EMA/ 657469/ 2013). 2013.
http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2013/10/WC500153147.pdf
.Accessed 09 Feb 2018.
5. Palmer E. Manufacturing glitch leaves novo insulin cartridges with bad fills. 2013.
https://www.fiercepharma.com/supply-chain/manufacturing-glitch-leaves-novo-insulin-cartridges-bad-fills
. Accessed 08 June 2018.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献